L’Oréal invests in US biotech company Debut to create active ingredients
US biotech company Debut has raised USD 34 million in Series B a funding round led by BOLD, L’Oréal’s corporate venture capital fund. Additional participating investors include Fine Structure Ventures, Material Impact, GS Futures, Cavallo Ventures, Cultivian Sandbox Ventures, ACVC…